R Dirk Allison Sells 12,500 Shares of Addus HomeCare Co. (NASDAQ:ADUS) Stock

Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $121.29 on Thursday. The firm has a market capitalization of $2.20 billion, a P/E ratio of 27.76, a PEG ratio of 2.15 and a beta of 1.04. The company’s fifty day moving average price is $127.91 and its 200-day moving average price is $123.51. Addus HomeCare Co. has a 1-year low of $85.43 and a 1-year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $1.03 EPS. Equities analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares during the period. Wasatch Advisors LP increased its holdings in Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after buying an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. raised its position in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Addus HomeCare by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares in the last quarter. Finally, State Street Corp grew its position in shares of Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after acquiring an additional 27,990 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on ADUS shares. KeyCorp started coverage on Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, TD Cowen boosted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.